| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Departments of Endocrinology (A.A., M.L.D., H.P.F.K.) and Geriatrics (H.J.J.V., M.M.S.), University Hospital Utrecht; Departments of Psychonomics (A.A., E.H.F.d.H.) and Medical Physiology and Sports Medicine (W.R.d.V.) Utrecht University; and Department of Endocrinology (E.A.v.d.V.) Free University Hospital, Amsterdam, The Netherlands
Address all correspondence and requests for reprints to: Hans P.F. Koppeschaar, Department of Endocrinology, University Hospital Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.
The GH/insulin-like growth factor-I (GH/IGF-I) axis is known to be involved in aging of physiological functions. Recent studies indicate that the GH/IGF-I axis may be associated with cognitive functioning. The aim of the present study was to determine whether the age-related decline in circulating levels of IGF-I, as an index of anabolic status, is associated with cognitive functions that are known to decline with aging, but not with cognitive functions not sensitive to aging.
Twenty five healthy older men with well-preserved functional ability participated in the study. We also administered neuropsychological tests of general knowledge, vocabulary, basic visual perception, reading ability, visuoconstructive ability, perceptual-motor speed, mental tracking, and verbal long-term memory. Performance on the last four tests decline with aging, whereas the first four of these tests have been shown not to be sensitive to cognitive aging. Mean age of the subjects was 69.1 ± 3.4 (SD) yr (range 6576 yr), their mean body mass index was 27.0 ± 2.4 kg/m2, and their mean IGF-I level was 122 ng/mL (range: 50220). We found IGF-I levels to be significantly associated with the performances (controlled for education) on the Digit Symbol Substitution test (r = 0.52, P = 0.009) and the Concept Shifting Task (r = -0.55, P = 0.005), which measure perceptual-motor and mental processing speed. Subjects with higher IGF-I levels performed better on these tests, performance on which is known to decline with aging.
In conclusion, the results of this study support the hypothesis that circulating IGF-I may play a role in the age-related reduction of certain cognitive functions, specifically speed of information processing.
This article has been cited by other articles:
![]() |
I C. van Nieuwpoort and M. L Drent Cognition in the adult with childhood-onset GH deficiency Eur. J. Endocrinol., December 1, 2008; 159(suppl_1): S53 - S57. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Sturman, C. F. M. de Leon, J. L. Bienias, M. C. Morris, R. S. Wilson, and D. A. Evans Body mass index and cognitive decline in a biracial community population Neurology, January 29, 2008; 70(5): 360 - 367. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sathiavageeswaran, P. Burman, D. Lawrence, A. G Harris, M. G Falleti, P. Maruff, and J. Wass Effects of GH on cognitive function in elderly patients with adult-onset GH deficiency: a placebo-controlled 12-month study Eur. J. Endocrinol., April 1, 2007; 156(4): 439 - 447. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. I. Okereke, J. H. Kang, J. Ma, J. M. Gaziano, and F. Grodstein Midlife Plasma Insulin-Like Growth Factor I and Cognitive Function in Older Men J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4306 - 4312. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Bonkowski, R. W. Pamenter, J. S. Rocha, M. M. Masternak, J. A. Panici, and A. Bartke Long-lived growth hormone receptor knockout mice show a delay in age-related changes of body composition and bone characteristics. J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2006; 61(6): 562 - 567. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Meyerhardt, J. A. Sloan, D. J. Sargent, R. M. Goldberg, M. Pollak, R. F. Morton, R. K. Ramanathan, S. K. Williamson, B. P. Findlay, and C. S. Fuchs Associations between Plasma Insulin-Like Growth Factor Proteins and C-Peptide and Quality of Life in Patients with Metastatic Colorectal Cancer Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1402 - 1410. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Smith, L. Betancourt, and Y. Sun Molecular Endocrinology and Physiology of the Aging Central Nervous System Endocr. Rev., April 1, 2005; 26(2): 203 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D. Borofsky, J. H. Vogelman, R. A. Krajcik, and N. Orentreich Utility of Insulin-like Growth Factor-1 as a Biomarker in Epidemiologic Studies Clin. Chem., December 1, 2002; 48(12): 2248 - 2251. [Full Text] [PDF] |
||||
![]() |
S. Asthana, L. D. Baker, S. Craft, F. Z. Stanczyk, R. C. Veith, M. A. Raskind, and S. R. Plymate High-dose estradiol improves cognition for women with AD: Results of a randomized study Neurology, August 28, 2001; 57(4): 605 - 612. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bartke, K. Coschigano, J. Kopchick, V. Chandrashekar, J. Mattison, B. Kinney, and S. Hauck Genes That Prolong Life: Relationships of Growth Hormone and Growth to Aging and Life Span J. Gerontol. A Biol. Sci. Med. Sci., August 1, 2001; 56(8): B340 - 349. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Arai, N. Hirose, K. Yamamura, K.-i. Shimizu, M. Takayama, Y. Ebihara, and Y. Osono Serum Insulin-like Growth Factor-1 in Centenarians: Implications of IGF-1 as a Rapid Turnover Protein J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2001; 56(2): 79M - 82. [Abstract] [Full Text] |
||||
![]() |
N. R. Glick, M. H. Fischer, and W. N. Adkins Jr The Influence of Nutrition on IGF-1 in Tube-Fed Profoundly Retarded Adults J. Am. Coll. Nutr., February 1, 2001; 20(1): 81 - 86. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kalmijn, J. A. M. J. L. Janssen, H. A. P. Pols, S. W. J. Lamberts, and M. M. B. Breteler A Prospective Study on Circulating Insulin-Like Growth Factor I (IGF-I), IGF-Binding Proteins, and Cognitive Function in the Elderly J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4551 - 4555. [Abstract] [Full Text] |
||||
![]() |
P. Sytze van Dam, H. E. C. Smid, W. R. de Vries, M. Niesink, E. Bolscher, E. J. Waasdorp, C. Dieguez, F. F. Casanueva, and H. P. F. Koppeschaar Reduction of Free Fatty Acids By Acipimox Enhances the Growth Hormone (GH) Responses to GH-Releasing Peptide 2 in Elderly Men J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4706 - 4711. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |